World's Best Scientists 2026 revealed!
Mohamad Mohty

Mohamad Mohty

D-Index & Metrics

Medicine

D-Index
108
Citations
40976
World Ranking
6027
National Ranking
173

Overview

Mohamad Mohty is a researcher affiliated with Inserm in France, primarily focused on the field of medicine with significant contributions to hematology. Their work spans a wide array of subfields including hematology, oncology, public health, molecular biology, and immunology.

The central themes in Mohty's research include hematopoietic stem cell transplantation and various hematological malignancies. Specific topics addressed in their publications cover:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Multiple Myeloma Research and Treatments
  • CAR-T Cell Therapy Research
  • Protein Degradation and Inhibitors
  • Polyomavirus and Related Diseases

Mohty has coauthored extensively with several frequent collaborators, indicating ongoing research partnerships. The most common coauthors include:

  • Arnon Nagler
  • Myriam Labopin
  • Fabio Ciceri
  • Didier Blaise
  • Éolia Brissot

In terms of publication venues, Mohty has appeared repeatedly in a number of specialized journals highlighting their research focus. Notable journals and the number of publications in each are:

  • Bone Marrow Transplantation (118 publications)
  • Blood (86 publications)
  • Transplantation and Cellular Therapy (22 publications)
  • American Journal of Hematology (19 publications)
  • Clinical Hematology International (18 publications)

Some of the recent papers associated with Mohamad Mohty's research portfolio include:

  • "Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease," 2020, published in New England Journal of Medicine
  • "Acute lymphoblastic leukaemia," 2020, published in The Lancet
  • "Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation," 2020, published in The Lancet Haematology
  • "Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results," 2023, published in Nature Medicine
  • "Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years," 2021, published in Bone Marrow Transplantation

Best Publications

  • Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

    Robert Zeiser;Nikolas von Bubnoff;Jason Butler;Mohamad Mohty

  • Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.

    Jean-Luc Harousseau;Michel Attal;Hervé Avet-Loiseau;Gerald Marit

  • Mechanisms of action of antithymocyte globulin : T-cell depletion and beyond

    M Mohty

  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    Olaf Penack;Monia Marchetti;Tapani Ruutu;Mahmoud Aljurf

  • Acute lymphoblastic leukaemia

    Florent Malard;Mohamad Mohty

  • The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

    Jan J. Cornelissen;Alois Gratwohl;Richard F. Schlenk;Jorge Sierra

  • Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

    Régis Peffault de Latour;Jean Yves Mary;Célia Salanoubat;Louis Terriou

  • Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

    Aurore Perrot;Valerie Lauwers-Cances;Jill Corre;Jill Corre;Nelly Robillard

  • Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire

    Steven Le Gouill;Noel Milpied;Agnès Buzyn;Régis Peffault De Latour

  • Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

    T. Ruutu;A. Gratwohl;T. De Witte;B. Afanasyev

  • Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

    Jakob R. Passweg;Helen Baldomero;Christian Chabannon;Grzegorz W. Basak

  • Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

    Ibrahim Yakoub-Agha;Christian Chabannon;Peter Bader;Grzegorz W. Basak

  • Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

    Dietger Niederwieser;Helen Baldomero;Jeff Szer;Michael Gratwohl

  • Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis

    Salut Brunet;Myriam Labopin;Jordi Esteve;Jan Cornelissen

  • Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.

    Reuben Benjamin;Reuben Benjamin;Charlotte Graham;Charlotte Graham;Deborah Yallop;Agnieszka Jozwik;Agnieszka Jozwik

  • Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

    Rafael F. Duarte;Myriam Labopin;Peter Bader;Grzegorz W. Basak

  • Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission

    A Ruggeri;M Labopin;F Ciceri;M Mohty

  • Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia

    Olle Ringdén;Myriam Labopin;Gerhard Ehninger;Dietger Niederwieser

  • Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Celso A. Rodrigues;Guillermo Sanz;Claudio G. Brunstein;Jaime Sanz

  • CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT

    Martin Schmidt-Hieber;Myriam Labopin;Dietrich Beelen;Liisa Volin

Frequent Co-Authors

Myriam Labopin
Myriam Labopin Université Paris Cité
Arnon Nagler
Arnon Nagler Sheba Medical Center
Gérard Socié
Gérard Socié Université Paris Cité
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha University of Lille
Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Mauricette Michallet
Mauricette Michallet University of Helsinki
Nicolaus Kröger
Nicolaus Kröger Universität Hamburg
Christoph Schmid
Christoph Schmid University of Augsburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees online can open diverse career opportunities for students interested in medicine. For those aiming at leadership roles, affordable online mha programs offer flexibility and cost-effectiveness while preparing graduates for hospital and clinical management positions.

Advanced practitioners such as nurse leaders and educators can benefit from the cheapest online dnp programs, which focus on clinical excellence and healthcare innovation. Pharmacy is another in-demand field, and studying through a pharmacy degree online enables working professionals to advance without putting their careers on hold.

For those interested in health data, rhia certification programs online allow students to qualify for roles in medical information management and healthcare technology oversight. Each pathway offers distinctive benefits, affordability, and the convenience of online learning, making them appealing options for students charting their future in healthcare.

Best Scientists Citing Mohamad Mohty

Trending Scientists

Recently Published Articles